Glaukos (GKOS) Non-Current Debt (2014 - 2015)

Glaukos (GKOS) reported Non-Current Debt of $765000.0 for Q4 2015, down 91.47% year-over-year from $9.0 million in Q4 2014, and down 74.83% quarter-over-quarter from $3.0 million in Q3 2015.

Glaukos (GKOS) Non-Current Debt (2014 - 2015) Analysis & Trends

Glaukos (GKOS) has 2 years of Non-Current Debt data on file, last reported at $765000.0 in Q4 2015.

  • Non-Current Debt for Q4 2015 came in at $765000.0, down 91.47% year-over-year; the trailing twelve-month figure through Dec 2015 was $765000.0 (down 91.47% YoY), and the FY2015 annual result was $765000.0, down 91.47% from the prior year.
  • Non-Current Debt retreated to $765000.0 in Q4 2015 per GKOS's latest filing, from $3.0 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $11.6 million in Q2 2015 and troughed at $765000.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 29.64 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 14.22 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 27.88 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 10.99 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 1.81 Bn
10 Glaukos 7.55 Bn 7.45 Bn 117.23 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2015 765,000.00
Dec 31, 2015 765,000.00
Sep 30, 2015 3.04 Mn
Sep 30, 2015 3.04 Mn
Jun 30, 2015 11.64 Mn
Jun 30, 2015 11.64 Mn
Dec 31, 2014 8.97 Mn
Dec 31, 2014 8.97 Mn